

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to nicotine (GO:0035095) | 5.14716936 |
| 2 | substrate-independent telencephalic tangential migration (GO:0021826) | 4.37660369 |
| 3 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 4.37660369 |
| 4 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.36493895 |
| 5 | presynaptic membrane organization (GO:0097090) | 4.30194799 |
| 6 | dopamine biosynthetic process (GO:0042416) | 4.19937416 |
| 7 | nonmotile primary cilium assembly (GO:0035058) | 4.07630404 |
| 8 | dendritic spine morphogenesis (GO:0060997) | 4.00093962 |
| 9 | presynaptic membrane assembly (GO:0097105) | 3.82060214 |
| 10 | establishment of mitochondrion localization (GO:0051654) | 3.73571998 |
| 11 | nucleobase catabolic process (GO:0046113) | 3.65075095 |
| 12 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.64056038 |
| 13 | mitochondrion transport along microtubule (GO:0047497) | 3.64056038 |
| 14 | prepulse inhibition (GO:0060134) | 3.63242054 |
| 15 | protein localization to synapse (GO:0035418) | 3.58605069 |
| 16 | axonal fasciculation (GO:0007413) | 3.54639806 |
| 17 | neuron recognition (GO:0008038) | 3.53312753 |
| 18 | neurofilament cytoskeleton organization (GO:0060052) | 3.42355558 |
| 19 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.34364682 |
| 20 | postsynaptic membrane organization (GO:0001941) | 3.33708787 |
| 21 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.30100203 |
| 22 | neuron cell-cell adhesion (GO:0007158) | 3.26418971 |
| 23 | dopamine transport (GO:0015872) | 3.24502442 |
| 24 | catechol-containing compound biosynthetic process (GO:0009713) | 3.20823774 |
| 25 | catecholamine biosynthetic process (GO:0042423) | 3.20823774 |
| 26 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.17408173 |
| 27 | auditory behavior (GO:0031223) | 3.13447673 |
| 28 | regulation of synapse structural plasticity (GO:0051823) | 3.12267163 |
| 29 | behavioral response to cocaine (GO:0048148) | 3.11800263 |
| 30 | mechanosensory behavior (GO:0007638) | 3.08393154 |
| 31 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.06640383 |
| 32 | synapse assembly (GO:0007416) | 3.03552888 |
| 33 | synaptic transmission, dopaminergic (GO:0001963) | 2.99537462 |
| 34 | cell migration in hindbrain (GO:0021535) | 2.99202850 |
| 35 | synaptic vesicle maturation (GO:0016188) | 2.98543511 |
| 36 | vocalization behavior (GO:0071625) | 2.97996441 |
| 37 | transmission of nerve impulse (GO:0019226) | 2.96952057 |
| 38 | adult walking behavior (GO:0007628) | 2.94816684 |
| 39 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.93480958 |
| 40 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.92970689 |
| 41 | central nervous system myelination (GO:0022010) | 2.90613338 |
| 42 | axon ensheathment in central nervous system (GO:0032291) | 2.90613338 |
| 43 | alkaloid metabolic process (GO:0009820) | 2.89776763 |
| 44 | positive regulation of synapse assembly (GO:0051965) | 2.87347281 |
| 45 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.84798317 |
| 46 | short-term memory (GO:0007614) | 2.84209803 |
| 47 | catecholamine transport (GO:0051937) | 2.83681759 |
| 48 | epithelial cilium movement (GO:0003351) | 2.83538137 |
| 49 | neuron-neuron synaptic transmission (GO:0007270) | 2.79692705 |
| 50 | toxin metabolic process (GO:0009404) | 2.78453629 |
| 51 | synaptic transmission, cholinergic (GO:0007271) | 2.77085468 |
| 52 | spinal cord development (GO:0021510) | 2.75561981 |
| 53 | adaptation of signaling pathway (GO:0023058) | 2.74895379 |
| 54 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.72645571 |
| 55 | synaptic transmission, glutamatergic (GO:0035249) | 2.69339774 |
| 56 | response to histamine (GO:0034776) | 2.68586477 |
| 57 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.67173192 |
| 58 | neuron fate determination (GO:0048664) | 2.66307648 |
| 59 | behavioral response to ethanol (GO:0048149) | 2.65994914 |
| 60 | serotonin metabolic process (GO:0042428) | 2.64139998 |
| 61 | positive regulation of gastrulation (GO:2000543) | 2.63868492 |
| 62 | glycerophospholipid catabolic process (GO:0046475) | 2.63828392 |
| 63 | negative regulation of appetite (GO:0032099) | 2.62610094 |
| 64 | negative regulation of response to food (GO:0032096) | 2.62610094 |
| 65 | membrane repolarization (GO:0086009) | 2.61749769 |
| 66 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.60173731 |
| 67 | intraciliary transport (GO:0042073) | 2.59845311 |
| 68 | protein localization to cilium (GO:0061512) | 2.58999530 |
| 69 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.57537023 |
| 70 | protein neddylation (GO:0045116) | 2.56964641 |
| 71 | response to amphetamine (GO:0001975) | 2.56379271 |
| 72 | membrane depolarization during action potential (GO:0086010) | 2.56075653 |
| 73 | regulation of dopamine secretion (GO:0014059) | 2.55946475 |
| 74 | cell proliferation in forebrain (GO:0021846) | 2.55321195 |
| 75 | somite rostral/caudal axis specification (GO:0032525) | 2.54989709 |
| 76 | glutamate receptor signaling pathway (GO:0007215) | 2.54840829 |
| 77 | olfactory bulb development (GO:0021772) | 2.53232568 |
| 78 | dendrite development (GO:0016358) | 2.51678826 |
| 79 | retinal ganglion cell axon guidance (GO:0031290) | 2.51381654 |
| 80 | axon extension (GO:0048675) | 2.49980012 |
| 81 | response to nicotine (GO:0035094) | 2.49543800 |
| 82 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.49274247 |
| 83 | phenol-containing compound catabolic process (GO:0019336) | 2.47390431 |
| 84 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.47093098 |
| 85 | neuronal ion channel clustering (GO:0045161) | 2.46162151 |
| 86 | somite development (GO:0061053) | 2.45503700 |
| 87 | brain morphogenesis (GO:0048854) | 2.45101114 |
| 88 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.44580615 |
| 89 | protein complex biogenesis (GO:0070271) | 2.43801756 |
| 90 | glutamate secretion (GO:0014047) | 2.43051102 |
| 91 | exploration behavior (GO:0035640) | 2.42454908 |
| 92 | dendrite morphogenesis (GO:0048813) | 2.42153173 |
| 93 | regulation of microtubule-based movement (GO:0060632) | 2.40145872 |
| 94 | primary amino compound metabolic process (GO:1901160) | 2.39319843 |
| 95 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.39281745 |
| 96 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.39234316 |
| 97 | membrane repolarization during action potential (GO:0086011) | 2.38148599 |
| 98 | response to auditory stimulus (GO:0010996) | 2.37877596 |
| 99 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.37801190 |
| 100 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.37442600 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.75706176 |
| 2 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.52349437 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.96366262 |
| 4 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.48553680 |
| 5 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.47560820 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 2.47476800 |
| 7 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.44777227 |
| 8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.36952592 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.30657718 |
| 10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.20787978 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.18125545 |
| 12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.13681776 |
| 13 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.12514076 |
| 14 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.12453475 |
| 15 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.09568976 |
| 16 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.06863686 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.06593355 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.95980241 |
| 19 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.94085501 |
| 20 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.90967524 |
| 21 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.84616570 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.84203419 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.83931204 |
| 24 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.83016936 |
| 25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.79298508 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.78426231 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.76253807 |
| 28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.73690434 |
| 29 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.73373003 |
| 30 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.73245643 |
| 31 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.72831169 |
| 32 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.72735474 |
| 33 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.71441086 |
| 34 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.71441086 |
| 35 | P300_19829295_ChIP-Seq_ESCs_Human | 1.70352260 |
| 36 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.63361086 |
| 37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.57865874 |
| 38 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.56107807 |
| 39 | FUS_26573619_Chip-Seq_HEK293_Human | 1.55457334 |
| 40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.55107569 |
| 41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.54161474 |
| 42 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.51556560 |
| 43 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.48703645 |
| 44 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.45889748 |
| 45 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.45691510 |
| 46 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.44760106 |
| 47 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.42286718 |
| 48 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.39116702 |
| 49 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.38105690 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36900894 |
| 51 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.35296711 |
| 52 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.34997702 |
| 53 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.34410039 |
| 54 | EWS_26573619_Chip-Seq_HEK293_Human | 1.32449251 |
| 55 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32337351 |
| 56 | AR_25329375_ChIP-Seq_VCAP_Human | 1.31871963 |
| 57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.30904898 |
| 58 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30887656 |
| 59 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.30887656 |
| 60 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.30474382 |
| 61 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.29995387 |
| 62 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28501091 |
| 63 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.27142035 |
| 64 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.26843951 |
| 65 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.26207288 |
| 66 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.24021202 |
| 67 | TCF4_23295773_ChIP-Seq_U87_Human | 1.21707950 |
| 68 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.19971514 |
| 69 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16908749 |
| 70 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.16695500 |
| 71 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.16433547 |
| 72 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.16433547 |
| 73 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.16195345 |
| 74 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.12985158 |
| 75 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12878577 |
| 76 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.11789492 |
| 77 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.10989306 |
| 78 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.09235547 |
| 79 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.08203664 |
| 80 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07549297 |
| 81 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07470564 |
| 82 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.07060915 |
| 83 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06450807 |
| 84 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.06295069 |
| 85 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.06218574 |
| 86 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.05817334 |
| 87 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.05085619 |
| 88 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.04924412 |
| 89 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.04422085 |
| 90 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.04259742 |
| 91 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.04073394 |
| 92 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.02563483 |
| 93 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.02329080 |
| 94 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.01808008 |
| 95 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.99830060 |
| 96 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.99696717 |
| 97 | JUN_21703547_ChIP-Seq_K562_Human | 0.99369764 |
| 98 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.98939394 |
| 99 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.98811387 |
| 100 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.97331885 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003787_abnormal_imprinting | 4.21246051 |
| 2 | MP0003122_maternal_imprinting | 3.16947472 |
| 3 | MP0002822_catalepsy | 3.06791703 |
| 4 | MP0003123_paternal_imprinting | 2.58873073 |
| 5 | MP0008877_abnormal_DNA_methylation | 2.52426262 |
| 6 | MP0003121_genomic_imprinting | 2.49288434 |
| 7 | MP0006292_abnormal_olfactory_placode | 2.39328819 |
| 8 | MP0004859_abnormal_synaptic_plasticity | 2.31599298 |
| 9 | MP0009046_muscle_twitch | 2.26238239 |
| 10 | MP0005423_abnormal_somatic_nervous | 2.26002321 |
| 11 | MP0000778_abnormal_nervous_system | 2.24639826 |
| 12 | MP0003880_abnormal_central_pattern | 2.23176319 |
| 13 | MP0001188_hyperpigmentation | 2.15394944 |
| 14 | MP0009745_abnormal_behavioral_response | 2.10085963 |
| 15 | MP0002272_abnormal_nervous_system | 2.07117792 |
| 16 | MP0003635_abnormal_synaptic_transmissio | 2.05108559 |
| 17 | MP0002909_abnormal_adrenal_gland | 2.02865996 |
| 18 | MP0005646_abnormal_pituitary_gland | 1.99514801 |
| 19 | MP0001905_abnormal_dopamine_level | 1.94263603 |
| 20 | MP0006276_abnormal_autonomic_nervous | 1.92057183 |
| 21 | MP0004270_analgesia | 1.92049791 |
| 22 | MP0001968_abnormal_touch/_nociception | 1.85830811 |
| 23 | MP0002734_abnormal_mechanical_nocicepti | 1.85167837 |
| 24 | MP0002837_dystrophic_cardiac_calcinosis | 1.82550060 |
| 25 | MP0001984_abnormal_olfaction | 1.82188544 |
| 26 | MP0001529_abnormal_vocalization | 1.81981515 |
| 27 | MP0002063_abnormal_learning/memory/cond | 1.81106492 |
| 28 | MP0008789_abnormal_olfactory_epithelium | 1.80023114 |
| 29 | MP0002572_abnormal_emotion/affect_behav | 1.77864668 |
| 30 | MP0005499_abnormal_olfactory_system | 1.75262458 |
| 31 | MP0005394_taste/olfaction_phenotype | 1.75262458 |
| 32 | MP0002557_abnormal_social/conspecific_i | 1.70077945 |
| 33 | MP0002735_abnormal_chemical_nociception | 1.67286393 |
| 34 | MP0005551_abnormal_eye_electrophysiolog | 1.65967531 |
| 35 | MP0002064_seizures | 1.65867508 |
| 36 | MP0004142_abnormal_muscle_tone | 1.65016478 |
| 37 | MP0005645_abnormal_hypothalamus_physiol | 1.61521523 |
| 38 | MP0002102_abnormal_ear_morphology | 1.61011942 |
| 39 | MP0002653_abnormal_ependyma_morphology | 1.59175036 |
| 40 | MP0002184_abnormal_innervation | 1.57331116 |
| 41 | MP0001486_abnormal_startle_reflex | 1.56894696 |
| 42 | MP0004133_heterotaxia | 1.54040523 |
| 43 | MP0000631_abnormal_neuroendocrine_gland | 1.53186830 |
| 44 | MP0001440_abnormal_grooming_behavior | 1.50498858 |
| 45 | MP0003890_abnormal_embryonic-extraembry | 1.47943841 |
| 46 | MP0001970_abnormal_pain_threshold | 1.46556954 |
| 47 | MP0002733_abnormal_thermal_nociception | 1.46231003 |
| 48 | MP0000955_abnormal_spinal_cord | 1.45095951 |
| 49 | MP0002067_abnormal_sensory_capabilities | 1.42531985 |
| 50 | MP0002638_abnormal_pupillary_reflex | 1.42422364 |
| 51 | MP0004742_abnormal_vestibular_system | 1.39762040 |
| 52 | MP0004924_abnormal_behavior | 1.33337030 |
| 53 | MP0005386_behavior/neurological_phenoty | 1.33337030 |
| 54 | MP0002736_abnormal_nociception_after | 1.32756652 |
| 55 | MP0004885_abnormal_endolymph | 1.32266202 |
| 56 | MP0002882_abnormal_neuron_morphology | 1.28604043 |
| 57 | MP0004145_abnormal_muscle_electrophysio | 1.25280865 |
| 58 | MP0006072_abnormal_retinal_apoptosis | 1.24905261 |
| 59 | MP0002163_abnormal_gland_morphology | 1.24753184 |
| 60 | MP0008872_abnormal_physiological_respon | 1.24596610 |
| 61 | MP0009379_abnormal_foot_pigmentation | 1.21517025 |
| 62 | MP0002752_abnormal_somatic_nervous | 1.18857603 |
| 63 | MP0005187_abnormal_penis_morphology | 1.18472732 |
| 64 | MP0003646_muscle_fatigue | 1.17877518 |
| 65 | MP0001986_abnormal_taste_sensitivity | 1.17521706 |
| 66 | MP0005379_endocrine/exocrine_gland_phen | 1.14514021 |
| 67 | MP0005195_abnormal_posterior_eye | 1.09613098 |
| 68 | MP0004811_abnormal_neuron_physiology | 1.09567646 |
| 69 | MP0001485_abnormal_pinna_reflex | 1.08129585 |
| 70 | MP0003195_calcinosis | 1.05174184 |
| 71 | MP0003011_delayed_dark_adaptation | 1.04366290 |
| 72 | MP0002152_abnormal_brain_morphology | 1.02458997 |
| 73 | MP0003942_abnormal_urinary_system | 1.01400138 |
| 74 | MP0001501_abnormal_sleep_pattern | 0.99241489 |
| 75 | MP0000427_abnormal_hair_cycle | 0.98347255 |
| 76 | MP0002229_neurodegeneration | 0.95946856 |
| 77 | MP0002066_abnormal_motor_capabilities/c | 0.95062667 |
| 78 | MP0001502_abnormal_circadian_rhythm | 0.94745525 |
| 79 | MP0001293_anophthalmia | 0.92649704 |
| 80 | MP0002938_white_spotting | 0.92084568 |
| 81 | MP0002876_abnormal_thyroid_physiology | 0.89555741 |
| 82 | MP0003315_abnormal_perineum_morphology | 0.88898532 |
| 83 | MP0005084_abnormal_gallbladder_morpholo | 0.88547080 |
| 84 | MP0003119_abnormal_digestive_system | 0.88496053 |
| 85 | MP0002234_abnormal_pharynx_morphology | 0.88254766 |
| 86 | MP0000049_abnormal_middle_ear | 0.88190329 |
| 87 | MP0000026_abnormal_inner_ear | 0.85370336 |
| 88 | MP0004085_abnormal_heartbeat | 0.84580384 |
| 89 | MP0003633_abnormal_nervous_system | 0.83273279 |
| 90 | MP0003861_abnormal_nervous_system | 0.82233020 |
| 91 | MP0005253_abnormal_eye_physiology | 0.80195970 |
| 92 | MP0001963_abnormal_hearing_physiology | 0.76253469 |
| 93 | MP0002233_abnormal_nose_morphology | 0.76063263 |
| 94 | MP0003879_abnormal_hair_cell | 0.75608014 |
| 95 | MP0003631_nervous_system_phenotype | 0.75402969 |
| 96 | MP0001944_abnormal_pancreas_morphology | 0.74431452 |
| 97 | MP0002069_abnormal_eating/drinking_beha | 0.73464230 |
| 98 | MP0002160_abnormal_reproductive_system | 0.73262078 |
| 99 | MP0002090_abnormal_vision | 0.69579546 |
| 100 | MP0002751_abnormal_autonomic_nervous | 0.69542857 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Limb dystonia (HP:0002451) | 5.97974550 |
| 2 | Myokymia (HP:0002411) | 4.08660254 |
| 3 | Molar tooth sign on MRI (HP:0002419) | 3.69964896 |
| 4 | Abnormality of midbrain morphology (HP:0002418) | 3.69964896 |
| 5 | Agitation (HP:0000713) | 3.68169976 |
| 6 | Pancreatic fibrosis (HP:0100732) | 3.51877998 |
| 7 | Medial flaring of the eyebrow (HP:0010747) | 3.50438194 |
| 8 | Gait imbalance (HP:0002141) | 3.39402065 |
| 9 | Nephronophthisis (HP:0000090) | 3.31020815 |
| 10 | Polyphagia (HP:0002591) | 3.18916334 |
| 11 | Hepatoblastoma (HP:0002884) | 3.15636232 |
| 12 | Epileptic encephalopathy (HP:0200134) | 3.09719964 |
| 13 | Focal motor seizures (HP:0011153) | 3.00020745 |
| 14 | Focal seizures (HP:0007359) | 2.93375730 |
| 15 | Congenital primary aphakia (HP:0007707) | 2.92570713 |
| 16 | True hermaphroditism (HP:0010459) | 2.86962146 |
| 17 | Febrile seizures (HP:0002373) | 2.82363603 |
| 18 | Drooling (HP:0002307) | 2.77641938 |
| 19 | Nephrogenic diabetes insipidus (HP:0009806) | 2.73931675 |
| 20 | Neoplasm of the adrenal cortex (HP:0100641) | 2.71963609 |
| 21 | Pancreatic cysts (HP:0001737) | 2.69534952 |
| 22 | Progressive cerebellar ataxia (HP:0002073) | 2.68931021 |
| 23 | Broad-based gait (HP:0002136) | 2.64372762 |
| 24 | Hypothermia (HP:0002045) | 2.59695990 |
| 25 | Abnormality of the renal medulla (HP:0100957) | 2.54809597 |
| 26 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.54630303 |
| 27 | Abnormal pancreas size (HP:0012094) | 2.51917063 |
| 28 | Excessive salivation (HP:0003781) | 2.50957581 |
| 29 | Chronic hepatic failure (HP:0100626) | 2.39872371 |
| 30 | Genital tract atresia (HP:0001827) | 2.39850328 |
| 31 | Hyperventilation (HP:0002883) | 2.36829651 |
| 32 | Acute necrotizing encephalopathy (HP:0006965) | 2.36742898 |
| 33 | Hypsarrhythmia (HP:0002521) | 2.35917131 |
| 34 | Vaginal atresia (HP:0000148) | 2.35795120 |
| 35 | EEG with generalized epileptiform discharges (HP:0011198) | 2.35275931 |
| 36 | Abnormal eating behavior (HP:0100738) | 2.35248215 |
| 37 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.32812359 |
| 38 | Epileptiform EEG discharges (HP:0011182) | 2.32656526 |
| 39 | Poor coordination (HP:0002370) | 2.30132475 |
| 40 | Anencephaly (HP:0002323) | 2.27199708 |
| 41 | Progressive macrocephaly (HP:0004481) | 2.26711878 |
| 42 | Abnormality of the labia minora (HP:0012880) | 2.24551596 |
| 43 | Generalized tonic-clonic seizures (HP:0002069) | 2.24110203 |
| 44 | Sclerocornea (HP:0000647) | 2.19851089 |
| 45 | Increased hepatocellular lipid droplets (HP:0006565) | 2.19815033 |
| 46 | Poor suck (HP:0002033) | 2.16757385 |
| 47 | Dialeptic seizures (HP:0011146) | 2.14964933 |
| 48 | Inability to walk (HP:0002540) | 2.13818722 |
| 49 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.13754600 |
| 50 | Atonic seizures (HP:0010819) | 2.11333173 |
| 51 | Lipid accumulation in hepatocytes (HP:0006561) | 2.11080370 |
| 52 | Decreased circulating renin level (HP:0003351) | 2.10731906 |
| 53 | Fetal akinesia sequence (HP:0001989) | 2.06540683 |
| 54 | Acute encephalopathy (HP:0006846) | 2.06396538 |
| 55 | Narrow forehead (HP:0000341) | 2.06285253 |
| 56 | Hemiparesis (HP:0001269) | 2.03333067 |
| 57 | Abnormality of the corticospinal tract (HP:0002492) | 2.03009741 |
| 58 | Renal Fanconi syndrome (HP:0001994) | 2.01689448 |
| 59 | Intestinal atresia (HP:0011100) | 2.01254835 |
| 60 | Adrenal hypoplasia (HP:0000835) | 1.99639832 |
| 61 | Mitochondrial inheritance (HP:0001427) | 1.98253110 |
| 62 | Muscular hypotonia of the trunk (HP:0008936) | 1.97411609 |
| 63 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.97133443 |
| 64 | Congenital stationary night blindness (HP:0007642) | 1.96644232 |
| 65 | Enlarged penis (HP:0000040) | 1.96586140 |
| 66 | Status epilepticus (HP:0002133) | 1.96567390 |
| 67 | Cystic liver disease (HP:0006706) | 1.95984592 |
| 68 | Methylmalonic acidemia (HP:0002912) | 1.95714435 |
| 69 | Pachygyria (HP:0001302) | 1.95065463 |
| 70 | Spastic tetraplegia (HP:0002510) | 1.94539970 |
| 71 | Abnormal drinking behavior (HP:0030082) | 1.93586153 |
| 72 | Polydipsia (HP:0001959) | 1.93586153 |
| 73 | Abnormality of renal resorption (HP:0011038) | 1.93569432 |
| 74 | Lissencephaly (HP:0001339) | 1.91699043 |
| 75 | Absence seizures (HP:0002121) | 1.91114520 |
| 76 | Osteomalacia (HP:0002749) | 1.89153209 |
| 77 | Specific learning disability (HP:0001328) | 1.88755031 |
| 78 | Oligodactyly (hands) (HP:0001180) | 1.87597097 |
| 79 | Optic nerve hypoplasia (HP:0000609) | 1.87066289 |
| 80 | Restlessness (HP:0000711) | 1.86492711 |
| 81 | Rib fusion (HP:0000902) | 1.82630011 |
| 82 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.82625264 |
| 83 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.80889578 |
| 84 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.80889578 |
| 85 | 3-Methylglutaconic aciduria (HP:0003535) | 1.80479360 |
| 86 | Pendular nystagmus (HP:0012043) | 1.80227457 |
| 87 | Abnormal hair whorl (HP:0010721) | 1.80101032 |
| 88 | Postaxial hand polydactyly (HP:0001162) | 1.79932884 |
| 89 | Double outlet right ventricle (HP:0001719) | 1.79384304 |
| 90 | Congenital malformation of the right heart (HP:0011723) | 1.79384304 |
| 91 | Hypogonadotrophic hypogonadism (HP:0000044) | 1.79006123 |
| 92 | Hypomagnesemia (HP:0002917) | 1.78945234 |
| 93 | Increased CSF lactate (HP:0002490) | 1.78887919 |
| 94 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.77937818 |
| 95 | Type II lissencephaly (HP:0007260) | 1.77460349 |
| 96 | Dyskinesia (HP:0100660) | 1.75505721 |
| 97 | Amblyopia (HP:0000646) | 1.75359798 |
| 98 | Congenital hepatic fibrosis (HP:0002612) | 1.75306057 |
| 99 | Male pseudohermaphroditism (HP:0000037) | 1.74549503 |
| 100 | Hyperphosphaturia (HP:0003109) | 1.74413932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.29758494 |
| 2 | STK16 | 4.10696875 |
| 3 | MARK1 | 3.34573755 |
| 4 | FRK | 3.33561528 |
| 5 | PINK1 | 3.20181148 |
| 6 | MAP3K4 | 2.73698421 |
| 7 | WNK4 | 2.52518030 |
| 8 | MAPK13 | 2.30222525 |
| 9 | MAP2K7 | 2.29759323 |
| 10 | NTRK2 | 2.24641622 |
| 11 | WNK3 | 2.16595093 |
| 12 | TNIK | 2.01455862 |
| 13 | NTRK3 | 2.01130442 |
| 14 | MAP3K9 | 1.88886984 |
| 15 | BMPR1B | 1.81022964 |
| 16 | STK39 | 1.78283709 |
| 17 | DYRK2 | 1.73705743 |
| 18 | MAP4K2 | 1.68212265 |
| 19 | CSNK1G2 | 1.67301635 |
| 20 | PAK3 | 1.63395727 |
| 21 | EPHA4 | 1.57390854 |
| 22 | ADRBK2 | 1.50551246 |
| 23 | MINK1 | 1.48655410 |
| 24 | PHKG2 | 1.47648451 |
| 25 | PHKG1 | 1.47648451 |
| 26 | CSNK1G1 | 1.46332959 |
| 27 | MAP2K4 | 1.42542993 |
| 28 | PNCK | 1.42179328 |
| 29 | PRKCG | 1.41931532 |
| 30 | TLK1 | 1.40528153 |
| 31 | CSNK1G3 | 1.39667756 |
| 32 | EPHB2 | 1.37158594 |
| 33 | MAPKAPK5 | 1.20640846 |
| 34 | GRK1 | 1.20017741 |
| 35 | MAP3K12 | 1.16124075 |
| 36 | DAPK2 | 1.05497841 |
| 37 | PLK2 | 1.01410365 |
| 38 | CAMK1G | 0.96734314 |
| 39 | FGFR2 | 0.96467682 |
| 40 | BCR | 0.96154095 |
| 41 | SGK223 | 0.95453995 |
| 42 | SGK494 | 0.95453995 |
| 43 | SIK2 | 0.94682777 |
| 44 | NUAK1 | 0.94612475 |
| 45 | SGK2 | 0.94274771 |
| 46 | OXSR1 | 0.93737035 |
| 47 | CDK5 | 0.91906270 |
| 48 | CAMK2A | 0.90827622 |
| 49 | ZAK | 0.89940228 |
| 50 | BCKDK | 0.88583857 |
| 51 | CAMK1D | 0.84883860 |
| 52 | BRAF | 0.81037154 |
| 53 | INSRR | 0.80355636 |
| 54 | STK11 | 0.79989177 |
| 55 | PIK3CA | 0.79885197 |
| 56 | CSNK1A1L | 0.76057868 |
| 57 | AKT3 | 0.75282048 |
| 58 | PRKCZ | 0.74678257 |
| 59 | PRKCE | 0.73927959 |
| 60 | CAMK2D | 0.73162261 |
| 61 | CAMK2B | 0.65705055 |
| 62 | DYRK1A | 0.60596743 |
| 63 | PRKACA | 0.58788426 |
| 64 | TRIM28 | 0.58031137 |
| 65 | DMPK | 0.57308462 |
| 66 | MAP3K11 | 0.56505339 |
| 67 | IRAK1 | 0.55091799 |
| 68 | SGK1 | 0.53873230 |
| 69 | PRKD3 | 0.52363771 |
| 70 | UHMK1 | 0.51447093 |
| 71 | GRK7 | 0.51235332 |
| 72 | CSNK1E | 0.50152114 |
| 73 | PKN1 | 0.49069492 |
| 74 | CAMK1 | 0.48771724 |
| 75 | CCNB1 | 0.48310995 |
| 76 | RPS6KA2 | 0.47211396 |
| 77 | PRKG1 | 0.46966076 |
| 78 | CAMKK2 | 0.45128419 |
| 79 | KSR1 | 0.44882004 |
| 80 | DYRK3 | 0.42267249 |
| 81 | ADRBK1 | 0.42088457 |
| 82 | CDK14 | 0.41644525 |
| 83 | CAMK2G | 0.41374735 |
| 84 | TIE1 | 0.41263579 |
| 85 | CAMKK1 | 0.40542021 |
| 86 | CSNK1A1 | 0.39525490 |
| 87 | MARK2 | 0.38545203 |
| 88 | PLK4 | 0.38492144 |
| 89 | SGK3 | 0.37842725 |
| 90 | PRKACB | 0.37452991 |
| 91 | MAP3K6 | 0.37067577 |
| 92 | GRK5 | 0.35720817 |
| 93 | TYRO3 | 0.35488882 |
| 94 | RPS6KA3 | 0.33388521 |
| 95 | LIMK1 | 0.33258437 |
| 96 | PRKAA1 | 0.32912184 |
| 97 | CSNK1D | 0.32854224 |
| 98 | ACVR1B | 0.32538400 |
| 99 | MKNK2 | 0.32398078 |
| 100 | CDK15 | 0.32196633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.23929843 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.84579907 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 2.54182101 |
| 4 | Cocaine addiction_Homo sapiens_hsa05030 | 2.41138427 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.41039083 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.29023442 |
| 7 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.11325613 |
| 8 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.07334037 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.05194814 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.02532250 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.02176444 |
| 12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.02175840 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 1.99380567 |
| 14 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.96297628 |
| 15 | Phototransduction_Homo sapiens_hsa04744 | 1.91044825 |
| 16 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.90836430 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.86775224 |
| 18 | Circadian entrainment_Homo sapiens_hsa04713 | 1.78624060 |
| 19 | Alzheimers disease_Homo sapiens_hsa05010 | 1.71641689 |
| 20 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.71301315 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.66980305 |
| 22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.66689227 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.62435264 |
| 24 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.61812807 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.57775778 |
| 26 | Huntingtons disease_Homo sapiens_hsa05016 | 1.53591825 |
| 27 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.42539854 |
| 28 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.35991858 |
| 29 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.28119874 |
| 30 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.25969737 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.24392389 |
| 32 | Protein export_Homo sapiens_hsa03060 | 1.23264821 |
| 33 | Long-term depression_Homo sapiens_hsa04730 | 1.21989288 |
| 34 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.21501952 |
| 35 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.18581202 |
| 36 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.14193920 |
| 37 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.11390932 |
| 38 | Axon guidance_Homo sapiens_hsa04360 | 1.08939807 |
| 39 | Peroxisome_Homo sapiens_hsa04146 | 1.00840837 |
| 40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.00711344 |
| 41 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.98274980 |
| 42 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.97229252 |
| 43 | Renin secretion_Homo sapiens_hsa04924 | 0.97212749 |
| 44 | Olfactory transduction_Homo sapiens_hsa04740 | 0.96961729 |
| 45 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.95836393 |
| 46 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.93794443 |
| 47 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.93010004 |
| 48 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.92766910 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.91563994 |
| 50 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.88640476 |
| 51 | Gap junction_Homo sapiens_hsa04540 | 0.85590049 |
| 52 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.85034186 |
| 53 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.84921176 |
| 54 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.82993538 |
| 55 | Salivary secretion_Homo sapiens_hsa04970 | 0.81216592 |
| 56 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.80619842 |
| 57 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.79780507 |
| 58 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.75950554 |
| 59 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.75353175 |
| 60 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.74315669 |
| 61 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.73405379 |
| 62 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.72724795 |
| 63 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.71232650 |
| 64 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.67362463 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.67086543 |
| 66 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.66761215 |
| 67 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.66312639 |
| 68 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.65840682 |
| 69 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.65679871 |
| 70 | Long-term potentiation_Homo sapiens_hsa04720 | 0.65350196 |
| 71 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.65000569 |
| 72 | Retinol metabolism_Homo sapiens_hsa00830 | 0.64791628 |
| 73 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.64055086 |
| 74 | Basal transcription factors_Homo sapiens_hsa03022 | 0.63098136 |
| 75 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.60160131 |
| 76 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.59646608 |
| 77 | Ribosome_Homo sapiens_hsa03010 | 0.58898223 |
| 78 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.58849633 |
| 79 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.58832074 |
| 80 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54777857 |
| 81 | Alcoholism_Homo sapiens_hsa05034 | 0.53901058 |
| 82 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.53007703 |
| 83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52989963 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.52650502 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.50940516 |
| 86 | Melanogenesis_Homo sapiens_hsa04916 | 0.49918873 |
| 87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.49440651 |
| 88 | Sulfur relay system_Homo sapiens_hsa04122 | 0.48699431 |
| 89 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.48451583 |
| 90 | RNA degradation_Homo sapiens_hsa03018 | 0.47352038 |
| 91 | RNA polymerase_Homo sapiens_hsa03020 | 0.47135939 |
| 92 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.46791455 |
| 93 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.46435284 |
| 94 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45972309 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.44807929 |
| 96 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.44403054 |
| 97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44395250 |
| 98 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.44390508 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43061285 |
| 100 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.41872215 |

